Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBI-5788 in Relapsing Multiple Sclerosis
NCT00079495Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Jul 2003
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of tiplimotide in multiple sclerosis (MS), sponsored by Neurocrine Biosciences. Started Jul 2003; status: completed.
02
Drugs
tiplimotide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00079495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079495.